The Medical Devices Regulations 2002
Typestatutory instrumentDate20 May 2002Articles171Versions held23Cited by113 documentsLast changed1 Apr 2026
- 1Citation and commencement
- 1zaExpiry of certain provisions in these Regulations
- 1aSchedules
- 2Interpretation
- 2aMedical devices which are qualifying Northern Ireland goods
- 3Scope of these Regulations
- 3zaRevocation, transitional and saving provisions in respect of Regulation (EU) 2017/745 and Regulation (EU)
- 3aDesignated standard
- 3bConfidentiality
- 4Transitional provisions
- 4aTransitional provisions for hip, knee and shoulder replacements
- 4dRevocations, transitional and saving provisions in respect of the new national registration requirements
- 4hRevocation of Commission Decision 2002/364 on 26th May 2025 and its effect before that date
- 4iRevocation of Commission Decision 2010/227
- 4jRevocation of Commission Regulation (EU) No 207/2012 on 26th May 2025
- 4kRevocation of Regulation (EU) No 722/2012 on 26th May 2025
- 4lRevocation of Regulation (EU) No 920/2013 on 26th May 2025 and its effect before that date
- 4mRevocation of Regulation (EU) No 2017/2185 and saving provision
- 4nThe classification criteria in Directives 2003/12 and 2005/50
- 4oRevocation of Regulation (EU) 2017/745
- 4pRevocation of Regulation (EU) 2017/746
- 4tReferences in other legislation to Directives 90/385, 93/42 and 98/79
- 5Interpretation of Part II
- 6Scope of Part II
- 7Classification of general medical devices
- 7aRegistration of persons placing general medical devices on the market
- 8Essential requirements for general medical devices
- 9Determining compliance of general medical devices with relevant essential requirements
- 10UK marking of general medical devices
- 10aUK(NI) indication: general medical devices
- 11UK marking of general medical devices that come within the scope of this Part and other legislation
- 12Exemptions from regulations 8 and 10
- 13Procedures for affixing a UK marking to general medical devices
- 14Procedures for systems and procedure packs, and for devices to be sterilised before use
- 15Procedures for custom-made general medical devices
- 16Procedures for general medical devices for clinical investigations
- 17Manufacturers etc. and conformity assessment procedures for general medical devices
- 18Approved bodies and the conformity assessment procedures for general medical devices
- 19Registration of persons placing general medical devices on the market
- 19aAdditional requirements relating to use of animal tissues
- 19bObligations in Part II of these Regulations which are met by complying with obligations in Directive 93/42
- 19cObligations in Part II and III of these Regulations which are met by complying with obligations in Regulat
- 20Interpretation of Part III
- 21Scope of Part III
- 21aRegistration of persons placing active implantable medical devices on the market
- 21bRegistration of persons placing active implantable medical devices on the market
- 21cRequirement to appoint a UK responsible person for active implantable medical devices
- 22Essential requirements for active implantable medical devices
- 23Determining compliance of active implantable medical devices with relevant essential requirements
- 24UK marking of active implantable medical devices
- 24aUK(NI) indication: active implantable medical devices
- 25UK marking of active implantable medical devices that come within the scope of this Part and other legislat
- 26Exemptions from regulations 22 and 24
- 27Procedures for affixing a UK marking to active implantable medical devices
- 28Procedures for custom-made active implantable medical devices
- 29Procedures for active implantable medical devices for clinical investigations
- 30Manufacturers etc. and conformity assessment procedures for active implantable medical devices
- 30aObligations in Part III which are met by complying with obligations in Directive 90/385
- 31Approved bodies and the conformity assessment procedures for active implantable medical devices
- 32Interpretation of Part IV
- 33Scope of Part IV
- 33aRegistration etc. of persons placing in vitro diagnostic medical devices on the market
- 34Essential requirements for in vitro diagnostic medical devices
- 34aApproval requirement for coronavirus test devices
- 34bPublic sector use of coronavirus test devices
- 34cTransitional provisions for coronavirus test devices
- 34dExemption for coronavirus test devices in conformity with Regulation (EU) 2017/746 and Regulation (EU) 202
- 35Determining compliance of in vitro diagnostic medical devices with relevant essential requirements
- 36UK marking of in vitro diagnostic medical devices
- 36aUK(NI) indication: in vitro diagnostic medical devices
- 37UK marking of in vitro diagnostic devices that come within the scope of this Part and other legislation
- 38In vitro diagnostic medical devices not ready for use
- 38aApplications for approval of coronavirus test devices
- 38bPerformance requirements for coronavirus test devices
- 38cRegister of approved coronavirus test devices
- 39Exemptions from this Part
- 39aExemptions for coronavirus test devices
- 40Procedures for affixing a UK marking to in vitro diagnostic medical devices
- 41Manufacturers etc. and conformity assessment procedures for in vitro diagnostic medical devices
- 42Approved bodies and the conformity assessment procedures for in vitro diagnostic medical devices
- 43Devices for performance evaluation
- 44Registration of persons placing in vitro diagnostic medical devices on the market or for performance evalua
- 44zaObligations in Part IV which are met by complying with obligations in Directive 98/79
- 44zbObligations in Part IV of these Regulations which are met by complying with obligations in Regulation (EU
- 44zcInterpretation of Part 4A
- 44zdScope of Part 4A
- 44zePost-market surveillance system
- 44zfPost-market surveillance plan
- 44zgPreventive and corrective actions
- 44zhInitial reporting of serious incidents
- 44ziInvestigation and final reporting of serious incidents
- 44zjField safety corrective actions and field safety notices
- 44zkField safety corrective actions outside Great Britain
- 44zlPost-market surveillance report
- 44zmPeriodic safety update report
- 44znTrend reporting
- 44zoReports received by the Secretary of State
- 44zpAnalysis of information received under Part 4A
- 44zqRetention of post-market surveillance documentation
- 44zrRequests for post-market surveillance documentation
- 44aInterpretation of Part V
- a45Meaning of approved body and UK notified body
- 45Designation etc. of approved bodies
- 46Choice of approved bodies and conformity assessment bodies
- 47General matters relating to approved bodies
- 47aRegister of approved bodies
- 48Designation etc. of … conformity assessment bodies
- 49Fees charged by approved bodies and conformity assessment bodies
- 50Products incorrectly marked with an approved body or conformity assessment body number
- 51Products incorrectly marked with a UK marking
- 52Interpretation of Part VI
- 53Fees in connection with the registration of devices and changes to registration details
- 54Fees payable in connection with the designation of approved bodies
- 55Fees payable in connection with the designation etc. of … conformity assessment bodies
- 56Fees payable in relation to clinical investigation notices
- 56aFees in connection with approval of coronavirus test devices
- 56bCircumstances in which a fee is payable in relation to a consultation on the safety, quality and usefulnes
- 56cFees payable in connection with a consultation or further consultation on the safety, quality and usefulne
- 56dFees payable in connection with pre-consultation meetings
- 56eFees payable in connection with regulatory advice meetings
- 57Unpaid fees
- 58Waivers, reductions and refunds
- 58aTime for payment of fees - small companies
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.